| Serial Number | 79296944 |
| Word Mark | B BRENUS PHARMA |
| Filing Date | Tuesday, August 25, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 23, 2021 |
| Registration Number | 6564692 |
| Registration Date | Tuesday, November 23, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 7, 2021 |
| Description of Mark | The mark consists of the black stylized wording "BRENUS" centered above the black stylized wording "PHARMA" with a short black line extending outward from each side of the wording "PHARMA", all of which is below a design of a light blue letter "B" that is surrounded by two light blue inverted triangles superimposed over one another with one appearing larger than the other. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark. |
| Description of the Colors Claimed | A first triangle in light blue partly superimposed on a second triangle in light blue, the letter "B" in light blue located in the area of intersection of the two triangles. Below the triangles, the verbal element "BRENUS" in black, and centered below the verbal element "BRENUS", the word "PHARMA" in black, with a black line on each side of the verbal element "PHARMA" |
| Goods and Services | Pharmaceutical products for treating pathologies that are controllable or curable by stimulated immunological reaction from a patient, namely, through infectious or oncological diseases; Veterinary products, namely, veterinary preparations for treating pathologies that are controllable or curable by stimulated immunological reaction from an animal, namely, through infectious or oncological diseases; Chemical preparations for pharmaceutical purposes, namely, for treating pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for medical or therapeutic purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for veterinary purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Pharmaceutical preparations, namely, immune system aids for use in human medicine; Diagnostic preparations for medical use; Diagnostic preparations for veterinary use; Immunostimulants under the pharmaceutical monopoly; medicines in the nature of vaccinal administrations for stimulating the immune system for use in human medicine; Serums under the pharmaceutical monopoly for medical purposes, namely, pharmaceutical serums for the treatment of the immune system; Biocellular preparations for therapeutic or medical purposes, namely, pharmaceutical preparations for the treatment of the immune system |
| Indication of Colors claimed | The color(s) light blue and black are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "PHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 30, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BRENUS PHARMA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | BRENUS PHARMA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | BRENUS PHARMA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Monday, July 24, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, June 6, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, May 12, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, May 11, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 23, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 23, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, September 11, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 7, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 7, 2021 | PUBLISHED FOR OPPOSITION |
| Monday, August 23, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 18, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 18, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 3, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 3, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 3, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 3, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 3, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, July 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, July 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, January 30, 2021 | REFUSAL PROCESSED BY IB |
| Saturday, January 9, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, January 9, 2021 | REFUSAL PROCESSED BY MPU |
| Thursday, December 24, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 23, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 23, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, November 3, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, October 30, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 29, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |